Clinical Trial Update: Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cognitive behavioral therapy with or without armodafinil for insomnia and fatigue in cancer survivors post-chemotherapy completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Fatigue
• Insomnia

Drugs mentioned

• Armodafinil (armodafinil)
• Cognitive behavioral therapy

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: COMPLETED